| HOME >> MEDICINE >> TECHNOLOGY |
Remember to tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
In patients with high LDL ("bad" cholesterol) side effects that occurred greater than placebo (a "sugar" pill) were constipation (11.0% vs. 7.0%), indigestion (8.3% vs. 3.5%), nausea (4.2% vs. 3.9%), accidental injury (3.7% vs. 2.7%), weakness (3.6% vs. 1.9%), sore throat (3.2% vs. 1.9%), flu-like symptoms (3.2% vs. 3.1%), runny nose (3.2% vs. 3.1%) and muscle aches (2.1% vs. 0.4%).
In patients with type 2 diabetes side effects that occurred greater than placebo were constipation (8.7% vs. 2.0%), inflamed nasal passages and throat (4.1% vs. 3.6%), indigestion (3.9% vs. 1.4%), low blood sugar (3.0% vs. 2.3%), nausea (3.0% vs. 1.4%) and high blood pressure (2.8% vs. 1.6%).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088.
For more information on Welchol, call 877-4-DSPROD (877-431-7763), or go to the Welchol web site at http://www.Welchol.com.
About Daiichi Sankyo, Inc.
Daiichi Sankyo Inc., headquartered in Parsippany, New Jersey, is the
U.S. subsidiary of Tokyo-based Daiichi Sankyo Co., Ltd. This global pharma
innovator was established in 2005 through the merger of two leading
Japanese pharmaceutical companies. The integration created a more robust
organization that allows for continuous development of novel drugs that
enrich the quality of life for patients around the world. A central focus
of Daiichi Sankyo's research and development is cardiovascular disease,
including therapies for dyslipidemia, hypertension, diabetes, and acute
coronary syndrome. Equally important t
'/>"/>
| SOURCE Daiichi Sankyo, Inc. (DSI) Copyright©2008 PR Newswire. All rights reserved |